Skip to main content
. 2018 Nov 30;51(11):557–562. doi: 10.5483/BMBRep.2018.51.11.056

Table 1.

Outcomes of various biomolecular pathways resulting from the production of ROS in gynecological cancers

Cancer Biomolecular process related to ROS Reference
Choriocarcinoma cancer • Inhibition of cell proliferation via cell cycle arrest and mitochondrial dysfunction (3941)
• EMT through controlling the cell cycle and migration ability (43)
Ovarian cancer • Apoptosis through inhibition of NADPH oxidase (10)
Endometrial cancer • Apoptosis via activation of the ERK and JNK pathways (56, 58)
• Inhibition of cell proliferation via activation of p38 (57)
• Metastasis or invasion via EMT-related transcription factors (59)